Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effects of Otago Exercise Program Vs Blind Folded Exercise on Falls, Balance and Quality of Life in Geriatric Population.

28 de agosto de 2026 atualizado por: Ibadat International University, Islamabad

As people age, maintaining balance can become more difficult, which increases the risk of dangerous falls. This clinical study aims to compare two different physical therapy programs to see which one is more effective at improving balance, reducing the frequency of falls, and enhancing the overall quality of life for older adults (aged 60 and older).

The first program is the Otago Exercise Program (OEP), which is a well-established, widely used routine focused on leg strengthening and active balance exercises. The second program is Blindfolded Exercise (BFE), which uses a safety harness or support bars while participants perform balance movements with their eyes covered. Temporarily removing vision forces the brain and body to rely more heavily on inner-ear balance systems (vestibular) and muscle/joint awareness (proprioception) to stay upright.

A total of 40 participants will be randomly assigned to one of these two exercise groups. Both groups will attend 30- to 45-minute physical therapy sessions, 3 times a week, for a total of 6 weeks. Researchers will assess participants' balance, walking speed, and overall quality of life at the beginning, middle, and end of the study to determine if sensory-deprived training (blindfolded) or muscle-strengthening training (Otago) offers better protection against falls.

Visão geral do estudo

Descrição detalhada

This study is a single-blinded, parallel-group, Randomized Controlled Trial (RCT) designed to compare the clinical efficacy of a strength-and-balance-based motor retraining program against a sensory-reweighting paradigm in community-dwelling older adults. The primary objective is to evaluate and contrast the effects of these distinct therapeutic approaches on postural stability, fall frequency, and health-related quality of life.

Participant Recruitment & Randomization:

Forty (40) participants aged 60 and older who meet the inclusion criteria will be recruited for this study. Eligible participants must have a history of a fall within the last three months, a Berg Balance Scale (BBS) score of 40 or lower, a positive Romberg test, and the ability to perform the Timed Up and Go (TUG) test. Following baseline assessments, participants will be randomly allocated to either Group 1 (Otago Exercise Program) or Group 2 (Blindfolded Exercise) in a 1:1 ratio using the sealed envelope randomization method.

Intervention Protocols:

All participants will undergo a 6-week intervention period consisting of 3 sessions per week, with each session lasting 30 to 45 minutes. Both groups will receive a standardized baseline physical therapy session (including a brief warm-up, heating pads, and light aerobic conditioning) prior to their specialized training:

  • Group 1: Otago Exercise Program (OEP): This progressive program focuses on lower limb muscle strengthening (targeting the quadriceps, hamstrings, gluteus medius, calves, and tibialis anterior) and progressive balance retraining (e.g., heel-to-toe walking, backward walking, and sit-to-stand transitions). Muscle-strengthening exercises will be progressively loaded using ankle weights (ranging from 500g up to 1kg) depending on individual tolerance, while balance activities will advance from supported to unsupported conditions.
  • Group 2: Blindfolded Exercise (BFE): This sensory-reweighting program utilizes temporary visual deprivation via a blindfold to limit visual input during functional balance exercises. Exercises are conducted under strict safety conditions (utilizing support bars, harnesses, and knee stabilizers as needed to prevent falls). The difficulty of the tasks will progress sequentially over the 6 weeks (e.g., transitioning from a supported wide-base stance to an unsupported tandem stance, and eventually to an unsupported single-leg stance, with eyes closed).

Outcome Measures & Assessment:

Clinical outcomes will be measured at three distinct time points: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6). The primary outcomes include:

  • Postural Balance: Assessed using the Berg Balance Scale (BBS).
  • Functional Mobility & Fall Risk: Evaluated using the Timed Up and Go (TUG) test.
  • Health-Related Quality of Life: Measured using the SF-36 health survey.

Statistical Analysis:

Data will be analyzed using SPSS software. Normality of the data will be assessed using the Shapiro-Wilk test. Within-group changes from baseline to post-intervention will be evaluated using paired-sample t-tests (or Wilcoxon signed-rank tests for non-parametric data). Between-group differences will be analyzed using independent-sample t-tests (or Mann-Whitney U tests). A Mixed-Model Analysis of Variance (ANOVA) will be utilized to determine the interaction effects between the groups over the three measurement intervals, with statistical significance set at p < 0.05.

Tipo de estudo

Intervencional

Inscrição (Real)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • KPK
      • Peshawar, KPK, Paquistão, 25000
        • Physioworks

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • History of fall within last 3 months.
  • Berg balance should be less than or equal to 40.
  • Patient age 60 and above.
  • Romberg test positive.

Exclusion Criteria:

  • Participants having cognition problems or a language barrier.
  • Physical disability (fracture or amputation).
  • Patient those have Secondary neurological condition (Parkinson's disease, stroke).
  • Previous surgery for last 6 weeks. Unstable Cardiovascular and pulmonary disease.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Otago Exercise Program Group (OEP)
Participants in this group will undergo a structured, progressive muscle-strengthening and balance-retraining program.
A 6-week progressive exercise program performed 3 times per week (30-45 minutes per session). It includes specific lower-limb muscle-strengthening exercises using progressive ankle weights (500g to 1kg) and progressive static/dynamic balance training (e.g., tandem walking, backward walking, sit-to-stand transitions).
Outros nomes:
  • standard physical therapy
Experimental: Blindfolded Exercise Group (BFE)
Participants in this group will undergo a progressive balance training program under temporary visual deprivation using a blindfold.
A 6-week sensory-reweighting balance program performed 3 times per week (30-45 minutes per session) with participants wearing a blindfold to eliminate visual cues. Exercises progress from wide-base supported stances to narrow-base and single-leg unsupported stances, conducted using strict safety measures (e.g., parallel bars, safety harnesses, and knee stabilizers).

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Berg Balance Scale (BBS)
Prazo: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 14-item objective measure designed to assess static balance and fall risk in adult populations. Each item is scored on a 5-point scale ranging from 0 (lowest function) to 4 (highest function), with a maximum total score of 56 points. Lower scores indicate poorer balance and higher fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
Berg Balance Scale(BBS)
Prazo: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 14-item objective measure designed to assess static balance and fall risk in adult populations. Each item is scored on a 5-point scale ranging from 0 (lowest function) to 4 (highest function), with a maximum total score of 56 points. Lower scores indicate poorer balance and higher fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Timed Up and Go (TUG) Test
Prazo: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A mobility and dynamic balance assessment that measures the time (in seconds) taken by a participant to rise from a standard armchair, walk 3 meters, turn around, walk back, and sit down. Shorter completion times indicate better functional mobility and lower fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
Quality of Life Assessment Tool SF 36 Model
Prazo: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 36-item self-reported questionnaire used to evaluate health-related quality of life across eight domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health. Scores for each domain range from 0 to 100, where higher scores indicate better health state and higher quality of life.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

7 de maio de 2026

Conclusão Primária (Real)

14 de julho de 2026

Conclusão do estudo (Real)

14 de julho de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

23 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

28 de agosto de 2026

Primeira postagem (Real)

1 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

1 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de agosto de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data (IPD) will not be shared publicly to maintain participant confidentiality and privacy in accordance with institutional review board (IRB) and ethical guidelines. Aggregate study results and outcomes will be made available through peer-reviewed publications.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever